uniQure Ownership | Who Owns uniQure?
uniQure Ownership Summary
uniQure is owned by 38.04% institutional investors, 5.53% insiders, and 56.43% retail investors. Avoro capital advisors is the largest institutional shareholder, holding 10.36% of QURE shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.47% of its assets in uniQure shares.
QURE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | uniQure | 38.04% | 5.53% | 56.43% |
| Sector | Healthcare Stocks | 35.64% | 12.08% | 52.28% |
| Industry | Biotech Stocks | 35.43% | 12.01% | 52.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Avoro capital advisors | 5.96M | 10.36% | $97.44M |
| Abrdn | 5.31M | 9.23% | $86.76M |
| Ecor1 capital | 3.99M | 7.28% | $232.84M |
| Jpmorgan chase | 2.84M | 4.93% | $41.80M |
| Two sigma investments, lp | 2.68M | 4.65% | $43.75M |
| Rtw investments, lp | 2.59M | 4.50% | $42.29M |
| Blackrock | 1.93M | 3.98% | $8.63M |
| State street | 2.26M | 3.93% | $36.96M |
| Orbimed advisors | 2.14M | 3.71% | $34.93M |
| Fmr | 1.74M | 3.03% | $28.51M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ecor1 capital | 3.99M | 11.17% | $232.84M |
| Whitefort capital management, lp | 657.61K | 3.17% | $10.75M |
| Boone capital management | 147.32K | 2.82% | $8.60M |
| Superstring capital management lp | 33.17K | 1.91% | $1.94M |
| Bioimpact capital | 1.37M | 1.73% | $22.39M |
| Catalio capital management, lp | 491.12K | 1.68% | $8.03M |
| Privium fund management b.v. | 486.52K | 1.66% | $7.95M |
| Lion point capital, lp | 14.70K | 1.44% | $240.34K |
| Boxer capital management | 662.00K | 1.42% | $10.82M |
| First turn management | 615.49K | 1.12% | $10.06M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Abrdn | 5.31M | 0.14% | 1.63M |
| Orbimed advisors | 2.14M | 0.70% | 1.40M |
| Two seas capital lp | 1.30M | 0.30% | 1.30M |
| Two sigma investments, lp | 2.68M | 0.04% | 1.22M |
| Siren | 1.00M | 0.45% | 1.00M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 1.74M | 0.00% | -4.50M |
| Suvretta capital management | - | - | -1.22M |
| Rtw investments, lp | 2.59M | 0.42% | -1.13M |
| Artia global partners lp | - | - | -1.02M |
| State street | 2.26M | 0.00% | -970.53K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Two seas capital lp | 1.30M | 0.30% | 1.30M | $21.25M |
| Jane street group | 636.00K | 0.00% | 636.00K | $10.40M |
| Mak capital one | 441.20K | 1.06% | 441.20K | $7.21M |
| Darwin global management | 400.00K | 0.66% | 400.00K | $23.76M |
| Vanguard fiduciary trust | 332.52K | 0.00% | 332.52K | $5.44M |
Sold Out
| Holder | Change |
|---|---|
| Whipplewood advisors | -1.00 |
| Nbc securities | -2.00 |
| Northwestern mutual wealth management | -3.00 |
| Larson financial group | -8.00 |
| Principal securities | -19.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 140 | -46.36% | 21,874,516 | -64.64% | 38 | 0.34% | 66 | -54.48% | 39 | -40.91% |
| Dec 31, 2025 | 175 | -32.17% | 37,757,618 | -31.79% | 64 | 0.72% | 97 | -36.60% | 43 | -31.75% |
| Sep 30, 2025 | 253 | 45.40% | 55,350,112 | 4.51% | 100 | 1.08% | 150 | 105.48% | 61 | 7.02% |
| Jun 30, 2025 | 170 | 3.66% | 52,946,969 | 5.89% | 96 | 1.09% | 75 | 2.74% | 54 | 31.71% |
| Mar 31, 2025 | 23 | -85.35% | 19,779,316 | -52.46% | 37 | 0.51% | 14 | -81.08% | 5 | -89.36% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 2.39M | 3.47% | -53.04K |
| RTW Biotech Opportunities Ord | 1.39M | 2.57% | 1.39M |
| abrdn World Healthcare | 1.26M | 1.84% | -10.35K |
| abrdn Healthcare Investors | 1.15M | 1.67% | -924.16K |
| SPDR® S&P Biotech ETF | 838.29K | 1.53% | 1.87K |
| Delaware Healthcare I | 706.17K | 1.45% | - |
| JPM US Mid Cap Growth-Composite | 959.05K | 1.39% | 395.40K |
| abrdn Healthcare Opportunities | 951.74K | 1.38% | -15.11K |
| Macquarie Healthcare I | 706.17K | 1.29% | - |
| Worldwide Healthcare Ord | 884.50K | 1.29% | 884.50K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 02, 2026 | Kapusta Matthew C | CEO, Managing Director | Sell | $348.76K |
| Jul 02, 2026 | Kapusta Matthew C | CEO, Managing Director | Sell | $194.53K |
| Jul 02, 2026 | Kapusta Matthew C | CEO, Managing Director | Sell | $408.76K |
| Jun 30, 2026 | Abi-Saab Walid | Chief Medical Officer | Sell | $464.60K |
| Jun 30, 2026 | Abi-Saab Walid | Chief Medical Officer | Sell | $928.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 35 |
| 2026 Q1 | - | 14 |
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 7 |
| 2025 Q2 | - | 9 |
QURE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools